Cell and Gene Therapy Weekly News - April 3rd 2025
Gene & Cell Therapy : Key Highlights in Vision, Heart, Neurological…
Cardiovascular Weekly News - April 3rd 2025
Latest Breakthroughs in Cardiovascular Health: Innovations & Expert…
Women's Health Weekly News - April 2nd 2025
Women's Health Watch: Breakthroughs and Innovations in MS Treatment,…
LucidTrends Analysis: Hemophilia B (US) - April 1st 2025
🔬 Hemophilia B Treatment Trends: Key Insights & Market Shifts 🩸 In this…
LucidTrends Analysis: Major Depressive Disorder (EU) - March 21st 2025
🔬 What’s Shaping the Future of MDD Treatment Searches Across Europe? Dive into…
AI-Powered Medical Affairs: Enhancing value, engagement, and insights
The pharmaceutical sector is witnessing a transformative shift fueled by the…
Unveiling the Financial Ties: HCPs, PAOs and Pharmaceutical Funding
The entanglement of financial relationships among healthcare professionals…
How we helped an established hemophilia player optimize its market access, pricing and reimbursement strategies in the US and EU5 markets.
The Challenge: How can an established player adapt its market access and…
How LucidQuest helped a company in the hemophilia space enhance its position in the market
The Challenge: How to unveil competitors' plans and gain a strategic edge A…
How LucidQuest Supported a leading pharma in Hemophilia to better position its Hemophilia A assets vs. a key competitor in the US
The Challenge: How can a Top-20 Pharma company uncover the key competitor's…
How a pharma in the digital respiratory space assessed its market positioning and refined its GTM strategy.
The Challenge: How to understand the go-to-market (GTM) strategies of key…
How LucidQuest helped a company in the depression space face its competition by delivering a workshop
The Challenge: How to develop effective counter-strategies in the depression…